Long-term recovery of survivors of coronavirus disease (COVID-19) treated with extracorporeal membrane oxygenation: The next imperative
Authors:
- Glenn J.R. WhitmanGWGlenn J.R. Whitman
- Ann M. ParkerAPAnn M. Parker
- Matthew F. MartMMMatthew F. Mart
- Joseph A. HippensteelJHJoseph A. Hippensteel
Open Access
- 1 March 2021
- journal article
- review article
- Published by Elsevier in JTCVS Open
- Vol. 5, 163-168
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Implementation of the Pain, Agitation, and Delirium Clinical Practice Guidelines and Promoting Patient Mobility to Prevent Post-Intensive Care SyndromeCritical Care Medicine, 2013
- Clinical Practice Guidelines for the Management of Pain, Agitation, and Delirium in Adult Patients in the Intensive Care UnitCritical Care Medicine, 2013
- Rehospitalization in a National Population of Home Health Care Patients with Heart FailureHealth Services Research, 2012
- Improving long-term outcomes after discharge from intensive care unitCritical Care Medicine, 2012
- The ICU Follow-Up Clinic: A New Paradigm for IntensivistsRespiratory Care, 2011
- Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysisThe Lancet Neurology, 2011
- Functional Disability 5 Years after Acute Respiratory Distress SyndromeNew England Journal of Medicine, 2011
- Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trialThe Lancet, 2009
- Cognitive, mood and quality of life impairments in a select population of ARDS survivorsRespirology, 2008
- Understanding, compliance and psychological impact of the SARS quarantine experienceEpidemiology and Infection, 2007